Skip to main content
Alivus Life Sciences Limited (NSE:ALIVUS)
India flag India · Delayed Price · Currency is INR
1,446.00
-8.90 (-0.61%)
Nov 12, 2026, 3:30 PM IST

Alivus Life Sciences Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
6,6975,6454,8564,7094,6704,187
Depreciation & Amortization
791.24722.14583.42497.78406.48369.2
Other Amortization
31.4331.4322.6736.7414.469.57
Loss (Gain) From Sale of Assets
7.575.418.2110.115.587.43
Loss (Gain) From Sale of Investments
-457.8-380.56-76.1531.66--
Stock-Based Compensation
---43.7531.8534.98
Provision & Write-off of Bad Debts
--4.81-3.7148.19
Other Operating Activities
1,028916.3309.79147.0364.97320.84
Change in Accounts Receivable
191.61-887.54-2,048378.6-1,336-592.15
Change in Inventory
-1,011-674.47-388.55-826.26-972.27-28.23
Change in Accounts Payable
229.97-126.77187.46-341.21907.79737.49
Change in Other Net Operating Assets
135.19403.37445.2-551.93-735.63881.29
Operating Cash Flow
7,6445,6543,9154,1353,0605,976
Operating Cash Flow Growth
76.66%44.41%-5.32%35.13%-48.79%53.97%

Investing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-3,836-3,071-1,662-1,290-1,628-1,322
Sale of Property, Plant & Equipment
6.476.476.294.651.744.69
Investment in Securities
-3,067-2,647-4,701-1.1128.05
Other Investing Activities
10.349.66200.13120.21157.6666.7
Investing Cash Flow
-6,887-5,702-6,156-1,165-1,467-1,222

Financing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Short-Term Debt Repaid
------9,329
Long-Term Debt Repaid
--80.21-44.86-22.09-11.28-13.65
Lease Payments
-75.45-80.21-44.86-22.09-11.28-13.65
Total Debt Repaid
-75.45-80.21-44.86-22.09-11.28-9,342
Net Debt Issued (Repaid)
-75.45-80.21-44.86-22.09-11.28-9,342
Issuance of Common Stock
51.25103.946.69--10,119
Common Dividends Paid
-613.85-613.41--2,757-3,859-1,287
Other Financing Activities
-54.16-53.72-24.14-15.46-5.47-277.64
Financing Cash Flow
-692.21-643.4-62.31-2,794-3,876-787.96

Net Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Cash Flow
64.89-690.8-2,304175.91-2,2833,966

Free Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
3,8082,5842,2532,8451,4324,654
Free Cash Flow Growth
59.23%14.65%-20.81%98.69%-69.23%45.39%
Free Cash Flow Margin
14.19%10.12%9.44%12.46%6.63%21.92%
Free Cash Flow Per Share
30.9521.0118.3423.1911.6939.60
Levered Free Cash Flow
2,6441,7151,3902,108553.753,756
Unlevered Free Cash Flow
2,6781,7491,4052,117557.173,931
Free Cash Flow After Leases
3,7322,5032,2092,8231,4214,640

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
54.1653.7224.1415.465.47277.64
Cash Income Tax Paid
1,8991,7331,6301,6301,5361,382
Change in Working Capital
-454.19-1,285-1,804-1,341-2,137998.4